APA (7th ed.) Citation

CY, H., MR, B., PN, P., G, S., IM, A., M, K., . . . MS, I. (2026). Innovative approaches to irinotecan-based therapies for glioblastoma: Advancements in drug delivery and combination strategies. Critical reviews in oncology/hematology, 219, 105144. https://doi.org/10.1016/j.critrevonc.2026.105144

Chicago Style (17th ed.) Citation

CY, Hsu, et al. "Innovative Approaches to Irinotecan-based Therapies for Glioblastoma: Advancements in Drug Delivery and Combination Strategies." Critical Reviews in Oncology/hematology 219 (2026): 105144. https://doi.org/10.1016/j.critrevonc.2026.105144.

MLA (9th ed.) Citation

CY, Hsu, et al. "Innovative Approaches to Irinotecan-based Therapies for Glioblastoma: Advancements in Drug Delivery and Combination Strategies." Critical Reviews in Oncology/hematology, vol. 219, 2026, p. 105144, https://doi.org/10.1016/j.critrevonc.2026.105144.